6 Results

People

  1. Morris
    Morris
  2. Beattie
    Beattie
  3. Humm
    Humm
  4. Scher
    Scher
  5. Lewis
    Lewis
  6. Zanzonico
    Zanzonico
  7. Burnazi
    Burnazi
  8. Finn
    Finn
  9. Larson
    Larson
  10. Lyashchenko
    Lyashchenko

Groups

  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Genitourinary Oncology Service (5)
  4. Radiology, Department of (5)
  5. Solid Tumor Oncology Division (5)
  6. Medical Physics (4)
  7. Molecular Imaging and Therapy Service (4)
  8. Center for Molecular Imaging and Biotechnology (3)
  9. Center for Pancreatic Cancer Research (3)
  10. Molecular Pharmacology and Chemistry Program Faculty (3)
  1. "fdht"
Formats
  1. Journal Article (6)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Genitourinary Oncology Service (5)
  4. Radiology, Department of (5)
  5. Solid Tumor Oncology Division (5)
  6. Medical Physics (4)

More Groups

People
  1. Michael Morris (5)
  2. Bradley Beattie (4)
  3. Howard Scher (4)
  4. John Humm (4)
  5. Jason Lewis (3)
  6. Pat Zanzonico (3)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2015 (1)
  5. 2010 (1)
  6. 2004 (1)
Publications
  1. Journal of Nuclear Medicine (4)
  2. Applied Radiation and Isotopes (1)
  3. Clinical Genitourinary Cancer (1)
Publishers
  1. Society of Nuclear Medicine (4)
  2. Elsevier Inc. (1)
  3. Pergamon-Elsevier Science Ltd (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of IGF-1R inhibitor cixutumumab and mTOR inhibitor temsirolimus in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D. J.; Chudow, J.; DeNunzio, M.; Slovin, S. F.; Danila, D. C.; Morris, M. J.; Scher, H. I.; Rathkopf, D. E.
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Assessment of simplified methods for quantification of (18)F-FDHT uptake in patients with metastatic castration-resistant prostate cancer
    Journal Article

    Kramer, G. M.; Yaqub, M.; Vargas, H. A.; Schuit, R. C.; Windhorst, A. D.; van den Eertwegh, A. J. M.; van der Veldt, A. A. M.; Bergman, A. M.; Burnazi, E. M.; Lewis, J. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Reproducibility and repeatability of semiquantitative (18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study
    Journal Article

    Vargas, H. A.; Kramer, G. M.; Scott, A. M.; Weickhardt, A.; Meier, A. A.; Parada, N.; Beattie, B. J.; Humm, J. L.; Staton, K. D.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Fully-automated synthesis of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) on the ELIXYS radiosynthesizer
    Journal Article

    Lazari, M.; Lyashchenko, S. K.; Burnazi, E. M.; Lewis, J. S.; Michael van Dam, R.; Murphy, J. M.
    Applied Radiation and Isotopes (2015)

    Fulltext@MSK | Save
  • Pharmacokinetic assessment of the uptake of 16β-18F-fluoro- 5α-dihydrotestosterone (FDHT) in prostate tumors as measured by PET
    Journal Article

    Beattie, B. J.; Smith-Jones, P. M.; Jhanwar, Y. S.; Schoder, H.; Ross Schmidtlein, C.; Morris, M. J.; Zanzonico, P.; Squire, O.; Meirelles, G. S. P.; Finn, R.; more...
    Journal of Nuclear Medicine (2010)

    Fulltext@MSK | Save
  • PET-based radiation dosimetry in man of 18F- fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer
    Journal Article

    Zanzonico, P. B.; Finn, R.; Pentlow, K. S.; Erdi, Y.; Beattie, B.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; McCarthy, T.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save